Skip to content

Phosphoplastin RL

by R 2 Diagnostics, Inc.

510(k) K040296Ref 11-310, 11-305

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 8 Nov 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), GUDID, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-10859394006030 Basic UDI-DI Date19 May 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number10859394006023 UDI-DI Date15 Nov 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK040296 Date24 May 2004ClearedStatusActive

Official records

From the FDA record

Received by the FDA
9 Feb 2004
FDA decision
24 May 2004 (Substantially Equivalent)
FDA review time
105 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K040296 (openFDA), as read on 8 Nov 2026. Quoted as published, gaps included; nothing on this list is generated.

FDA GUDID

UDI-DI 10859394006023
PT reagent 10 x 5 ml
UDI-DI 10859394006030
PT reagent 10 x 10 ml

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-10859394006030 registered 19 May 2026 Active
  • FDA 510(k) K040296 decided 24 May 2004 Active
  • FDA GUDID UDI-DI 10859394006023 listed 15 Nov 2016 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K040296
  2. Listed FDA GUDID 10859394006023
  3. Registered EUDAMED B-10859394006030

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k) · GUDID

Generic name
Prothrombin time (PT) IVD, reagent
Model / Ref / Catalog
11-305, 11-310
Description
PT reagent 10 x 5 ml
PT reagent 10 x 10 ml
FDA applicant
R2 Diagnostics, Inc.
Primary DI / UDI-DI
10859394006023, 10859394006030
Basic UDI-DI
B-10859394006030, B-10859394006023
510(k) Number
FDA product code
GJS
EMDN code
W0103020101 Prothrombin time ( quick test )
GMDN term
Prothrombin time (PT) IVD, reagent
Device class
Class IVD General EUDAMED
Class II 510(k)GUDID
Regulation
21 CFR Part 864.7750
EU registration type
Legacy device (under a directive)
EU market of registration
Italy
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent
GUDID distribution status
In Commercial Distribution

Truth per registry

3 sources · 1 field differs

FieldEUDAMED510(k)GUDID
Device classEUDAMED
Class IVD General
510(k)
Class II
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA 510(k), FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Phosphoplastin RL is a liquid thromboplastin reagent used in the one-stage prothrombin time (PT) test, a critical in vitro diagnostic assay for assessing coagulation function. It is designed for extrinsic factor assays and therapeutic monitoring of anticoagulant drugs such as Warfarin, enabling clinicians to evaluate coagulopathies and monitor hemostasis.

The device is supplied as a liquid reagent intended for single-use in clinical coagulation laboratories. It is classified as a Class II medical device under FDA regulations (864.7750) and has received both FDA 510(k) clearance and In Vitro Diagnostic Device (IVDD) authorization. Storage and handling conditions are not specified in the provided data, but standard laboratory practices for sensitive reagents should be followed.

Devices cleared under K040296

4 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K040296
UDI-DISize and differences
Phosphoplastin RL 11-305
r2 Diagnostics Inc.
11-305 / 11-30510859394006023
Prescription: no
On the market
Phosphoplastin RL 11-310
r2 Diagnostics Inc.
11-310 / 11-31010859394006030
Prescription: no
On the market
Thromboplastin-LI Reagent Kit 5248
Helena Laboratories, Corp.
5248M52552480
Prescription: yes
On the market
Thromboplastin-LI Reagent Kit 5249
Helena Laboratories, Corp.
5249M52552490
Prescription: yes
On the market

Similar devices in this category

Other devices filed under PROTHROMBIN TIME ( QUICK TEST ).

Other devices from R 2 Diagnostics, Inc.

See all devices from R 2 Diagnostics, Inc. →

Properties

  • Single use
  • Contains animal tissues or cells NoEUDAMEDYesEUDAMED
  • Reagent
  • IVD kit
  • Professional testing
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)